Close

Strep B

Streptococcus agalactiae or Group B strep is a gram-positive bacterium that expresses the Lancefield group B specific carbohydrate antigen on the cell wall. The prevalence of this bacterium in pregnant women as asymptomatic carriers is estimated to be 1 in 4, and its transmission during birth (early onset transmission) or after birth (late-onset transmission) to a newborn can have a fatality rate as high as 50%. Testing pregnant women in the third trimester is the recommended timeframe, and enzyme-linked immune assays and lateral flow may provide rapid diagnostic benefits in managing transmission to neonates and infants.

Have questions about a product?

Contact us to learn more about Meridian’s molecular or immunoassay reagent portfolio. We want to hear from you!

Contact A Specialist
Filter By:
Clear Results
4 Results
Name
Type
Format
Host/Source
Isotype
Tested Apps
Unit
Catalog
SDS
COA
Request Sample
Streptococcus Group B
Biotin
Rabbit
N/A
IFA
ML
B65527B
Streptococcus Group B
Aff.Pur.
Rabbit
N/A
IFA
ML
B65527R
Streptococcus Group B
HRP
Rabbit
N/A
EIA
ML
B65524P
MAb to Strep Agalactiae
Monoclonal
Purified
Mouse
IgG1
EIA
MG
C55560M

Get in Touch With A Specialist

Have questions about a product? Want to learn more about Meridian’s molecular or immunoassay reagent portfolio? We want to hear from you!

By submitting your information in this form, you agree that your personal information may be stored and processed in any country where we have facilities or service providers, and by using our “Contact Us” page you agree to the transfer of information to countries outside of your country of residence, including to the United States, which may provide for different data protection rules than in your country. The information you submit will be governed by our Privacy Statement.

Learn More About Us

Learn More

Welcome to

Please select your country to continue

Continue
CN